US Patent 8530404 Compounds and methods for treatment of cancer
Patent 8530404 was granted and assigned to Fibrogen, Inc. on September, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8530404 Compounds and methods for treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
